Element Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,147
| Closed | -$404K | – | 508 |
|
|
2019
Q1 | $404K | Buy |
5,147
+1,157
| +29% | +$90.8K | 0.01% | 505 |
|
|
2018
Q4 | $338K | Sell |
3,990
-484
| -11% | -$41K | 0.01% | 412 |
|
|
2018
Q3 | $766K | Buy |
4,474
+1,744
| +64% | +$299K | 0.02% | 379 |
|
|
2018
Q2 | $353K | Sell |
2,730
-123
| -4% | -$15.9K | 0.01% | 487 |
|
|
2018
Q1 | $294K | Buy |
+2,853
| New | +$294K | 0.01% | 484 |
|